Exelon Investor Alert:  February 14, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities.of Exelon Corporation (“Exelon” or the “Company”) (Nasdaq: EXC) between February 9, 2019 and November 1, 2019, inclusive (the “Class Period”). [Read more…]

HEXO Investor Alert: January 27, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities image

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased or otherwise acquired the common stock of  HEXO Corp. (“HEXO” or the “Company”) (NYSE: HEXO) between January 25, 2019 and November 15, 2019, inclusive (the “Class Period”). [Read more…]

Plantronics Shareholders: January 13, 2020 Filing Deadline in Securities Class Action

securities

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Plantronics, Inc. (“Plantronics” or the “Company”) (NYSE: PLT) between January 2, 2018 and November 5, 2019, inclusive (the “Class Period”). [Read more…]

Baxter Shareholder Alert: January 24, 2020 Filing Deadline in Class Action– Contact Lieff Cabraser

generic securities image

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of  Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the “Class Period”). [Read more…]

Exelon Shareholder Alert: February 14, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

Securities Class Litigation

SAN FRANCISCO, CA – (December 26, 2019) – The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Exelon Corporation (“Exelon” or the “Company”) (Nasdaq: EXC) between February 9, 2019 and November 1, 2019, inclusive (the “Class Period”). [Read more…]

HEXO Corp. Shareholder Class Action:  January 27, 2020 Filing Deadline – Contact Lieff Cabraser

generic securities image

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of HEXO Corp. (“HEXO” or the “Company”) (NYSE: HEXO) between January 25, 2019 and November 15, 2019, inclusive (the “Class Period”). [Read more…]

Baxter International Inc. Shareholder Class Action: January 24, 2020 Filing Deadline – Contact Lieff Cabraser

generic securities image
Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the “Class Period”).

[Read more…]

Chemours Shareholder Class Action: Reminder about December 9, 2019 Filing Deadline – Contact Lieff Cabraser

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the common stock of The Chemours Company (“Chemours” or the “Company”) (NYSE:CC) between February 16, 2017 and August 1, 2019, inclusive (the “Class Period”). [Read more…]

Myriad Genetics Investors: Filing Deadline in MYGN Class Action Approaches – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

Lieff Cabraser reminds investors that securities fraud class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]

The Chemours Company Investors: December 9, 2019 Filing Deadline in CC Class Action – Contact Lieff Cabraser

The Chemours Company Investors: December 9, 2019 Filing Deadline in CC Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA – (October 25, 2019) – The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces announces that securities fraud class action litigation has been filed on behalf of investors who purchased or otherwise acquired the common stock of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) between February 16, 2017 and August 1, 2019, inclusive (the “Class Period”). [Read more…]

Plaintiffs Provide Notice to Wells Fargo Shareholders of $320 Million Settlement of Wells Fargo Shareholder Derivative Litigation

Securities Fraud

San Francisco—(BUSINESSWIRE)–IN RE WELLS FARGO & COMPANY SHAREHOLDER DERIVATIVE LITIGATION, Lead Case No. 3:16-cv-05541-JST (N.D. Cal.)

TO: ALL RECORD AND BENEFICIAL OWNERS OF WELLS FARGO & COMPANY COMMON STOCK AS OF FEBRUARY 26, 2019 (THE “RECORD DATE”), WHO CONTINUE TO OWN SUCH SHARES (“WELLS FARGO SHAREHOLDERS”)

YOU ARE HEREBY NOTIFIED, that pursuant to an Order of the United States District Court for the Northern District of California, a hearing will be held on August 1, 2019, at 2 p.m., before the Honorable Jon S. Tigar, United States District Judge, at the United States District Court for the Northern District of California, 450 Golden Gate Avenue, San Francisco, California 94102, for the purpose of determining whether the proposed settlement of the above captioned derivative action (the “Derivative Action”), with a total settlement value of $320 million (as described below), should be approved as fair, reasonable and adequate, and whether a judgment dismissing the Defendants (as identified in the Stipulation of Settlement (“Stipulation”)) from the Derivative Action with prejudice should be entered. [Read more…]

$320M Wells Fargo Derivative Suit Settlement Granted First Round of Approval

Securities Fraud

A California federal judge has granted preliminary approval to a proposed $320 million settlement that would end shareholders’ derivative litigation relating to Wells Fargo’s fake accounts scandal. Plaintiffs in the suit, including the Fire & Police Pension Association of Colorado and the City of Birmingham Retirement and Relief System allege that since at least 2011, the Board and executive management of Wells Fargo knew or consciously disregarded that its employees were illicitly creating millions of deposit and credit card accounts for their customers, without those customers’ consent, in order to meet aggressive sales goals. [Read more…]

Lieff Cabraser to Proceed with Lawsuit in Denmark for Money Laundering Fraud Against Danske Bank

Securities and financial fraud

Lieff Cabraser, working with an international coalition of law firms including Danish law firm Németh Sigetty, will proceed with a lawsuit against Danske Bank A/S (“Danske” or the “Bank”) to pursue compensation for damaged investors after revelations of alleged money laundering, financial mismanagement, and deficient regulatory disclosures. [Read more…]

The Intercept: Will Shareholders Lose the Right to Sue Over Corporate Fraud?

Securities and financial fraud

In partnership with the Investigative Fund, The Intercept has published a powerful piece calling attention to proposed changes to the securities laws that may keep shareholders from being able to sue corporations that violate the law to shareholders’ detriment. The right to a trial may be replaced with mandatory arbitration agreements that will shunt shareholder lawsuits into private, closed-door arbitration funded by the very corporations alleged to have committed the fraud. [Read more…]

“Where are the Gatekeepers?” Bruce Leppla to Speak at the Investment Company Institute May 2017 General Members Meeting

Bruce Leppla to Speak at the Investment Company Institute May 2017 General Members Meeting

Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Investment Company Institute’s May 4, 2017 General Members Meeting on “Where are the Gatekeepers? The Need for Investment Firm Oversight of the Capital Markets.” Mr. Leppla and his partners represent institutional investors in major class and opt-out investment loss recovery litigation in circumstances where such losses are due to fraud or serious corporate misconduct. [Read more…]

Michael Miarmi to Discuss Fraud-on-the-Market Theory

Michael Miarmi to Discuss Fraud-on-the-Market Theory

Lieff Cabraser attorney Michael Miarmi will participate in a live CLE webcast addressing landmark securities fraud decisions on December 17, 2015. “Fraud-on-the-Market Theory: Presumption and Other Significant Issues and Updates in 2016 and Beyond Live Webcast” will be held on Thursday, December 17 from noon to 12 p.m. (Eastern). The discussion will center around the June 2014 U.S. Supreme Court decision in Halliburton Co. v. Erica P. John Fund, Inc. in which the foundation of securities class actions was called into question. [Read more…]

Bruce Leppla to Speak at the Legal Executive Institute

Bruce Leppla to Speak at the Legal Executive Institute on Intellectual Property Valuation Issues in Merger and Acquisition Litigation

Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Legal Executive Institute’s October 8, 2015 meeting on Board of Director fiduciary duties related to intellectual property valuation in the context of merger and acquisition (M&A) activity. With the dramatic rise of M&A activity involving the acquisition of companies with valuable intellectual property, the issue arises as to whether the Board of the company to be acquired has taken appropriate steps to value its intellectual property. Conventional valuation methods (e.g., discounted cash flow analysis, the use of comparables, etc.) may be of limited help. Mr. Leppla will examine the legal standards with respect to board fiduciary duty in this area and also review new, more innovative financial methods to assess valuation.

[Read more…]

Joy A. Kruse and Dean M. Harvey Discuss Class Action Trends

Joy A. Kruse and Dean M. Harvey Discuss Class Action Trends

Lieff Cabraser partners Joy A. Kruse and Dean M. Harvey will be discussing the latest trends in class actions at the Eleventh Annual Comprehensive Conference on Class Actions on June 4th & 5th in Seattle, Washington. Hosted by Law Seminars International, the conference will bring together distinguished practitioners in state and federal class actions. Ms. Kruse will address developments in securities law on a panel entitled “Raising Capital: Class Actions and Market Manipulation.” Mr. Harvey will speak on the “Cases at the Intersection of Class Actions and Employee Protection Regulations” panel.

[Read more…]

Nicholas Diamand Speaks at ICGN Annual Conference

Nicholas Diamand Speaks at ICGN Annual Conference

Lieff Cabraser attorney Nicholas Diamand will be participating at the 2015 International Corporate Governance Network (ICGN) Annual Conference hosted by the City of London, at Guildhall from June 3-5, 2015. Diamand will chair a panel on “Legal Redress as a Corporate Governance Element of Shareholder Engagement: An International Perspective.” Institutional investors from the United Kingdom, Europe, and Australia will discuss the regional approaches to investor protection litigation and recovery.

[Read more…]